CTCs were detected in 88.1% of HCC patients and CTCs with the expression of CD44 were observed in 71.4% of HCC patients. CTCs with GPC3, CS and HepPar-1 markers had a cancer stemness phenotype. Wan et al., 2019 (93). The gene discussed is CS; the disease is hepatocellular carcinoma.